Notes to SEFA
As mentioned in Note 8 to the financial statements, BVARI provides services to the VA Boston Healthcare System under a Memorandum of Understanding (MOU). Funding used under this MOU is provided through Interagency Agreements between the National Institute of Health (NIH), the Department of Defense (DoD) or Food and Drug Administration (FDA) and the Department of Veterans Affairs. BVARI provides support to the VA Precision Medicine Initiative Cohort Program (PMI-CP) for administrative, data management, extraction and storage of specimens, as well as health records and survey data, collected from Veterans who enroll into the Precision Medicine Program. BVARI provides support on the “NCI and VA Interagency Group to Accelerate Trials Enrollment” (NAVIGATE) program between NIH and the VA. Spending under the PMI-CP MOU amounted to $3,162,689 for the year ended September 30, 2025. Spending under the PMI-CP (DoD) MOU amounted to $127,600 for the year ended September 30, 2025. Spending under the NAVIGATE (NIH) MOU amounted to $590,076 for the year ended September 30, 2025. Spending under the FDA MOU amounted to $80,748 for the year ended September 30, 2025. Although these funds are sourced from the Federal government, they are not considered expenditures of Federal Grant Awards for the purpose of the Schedule of Expenditures of Federal Awards and are therefore not included on that schedule.